TALS Insider Trading Activity and SEC Form 4 Filings
TALS insider trading summary
No open-market insider purchases or sales of Talaris Therapeutics, Inc. (TALS) have been reported on SEC Form 4 in the past 12 months.
Latest TALS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 14, 2023 | Suzanne Ildstad | Director | Sell | $32K (12,942 @ $2.49) |
| Jun 13, 2023 | Suzanne Ildstad | Director | Sell | $36K (14,208 @ $2.56) |
| Jun 12, 2023 | Suzanne Ildstad | Director | Sell | $44K (16,870 @ $2.59) |
| Jun 9, 2023 | Suzanne Ildstad | Director | Sell | $63K (25,419 @ $2.46) |
| Jun 8, 2023 | Suzanne Ildstad | Director | Sell | $101K (40,642 @ $2.48) |
| Jun 7, 2023 | Suzanne Ildstad | Director | Sell | $179K (75,001 @ $2.39) |
| Jun 6, 2023 | Suzanne Ildstad | Director | Sell | $65K (25,549 @ $2.53) |
| Jun 5, 2023 | Suzanne Ildstad | Director | Sell | $20K (7,841 @ $2.52) |
| Jun 2, 2023 | Suzanne Ildstad | Director | Sell | $40K (15,818 @ $2.50) |
| Jun 1, 2023 | Suzanne Ildstad | Director | Sell | $40K (15,713 @ $2.56) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.